Inventor · disambiguated record
Jonathan Shannon
Also filed as: SHANNON JONATHAN · SHANNON JONATHAN MARTIN
21 granted patents·13 pending applications·25 citations·filing 2016–2024
91Inventor score
Top patents by PatentIndex Score
34 records- 0192US11001575B1Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2019·Granted May 11, 2021·4 cites·26 claims
- 0291US11981667B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2022·Granted May 14, 2024·1 cites·8 claims
- 0391US10457669B2Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2016·Granted Oct 29, 2019·5 cites·25 claims
- 0490US11370776B2Sulfonylureas and sulfonylthioureas as NLRP3 inhibitorsINFLAZOME LTD·Filed 2018·Granted Jun 28, 2022·6 cites·19 claims
- 0583US11465992B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Oct 11, 2022·1 cites·37 claims
- 0682US2024368136A1Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0781US11613542B2Sulfonylureas and sulfonylthioureas as NLRP3 inhibitorsINFLAZOME LTD·Filed 2018·Granted Mar 28, 2023·2 cites·32 claims
- 0880US11542255B2Sulfonylureas and sulfonylthioureas as NLRP3 inhibitorsINFLAZOME LTD·Filed 2018·Granted Jan 3, 2023·2 cites·24 claims
- 0980US11518739B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Dec 6, 2022·2 cites·22 claims
- 1079US11623922B2CompoundsINFLAZOME LTD·Filed 2018·Granted Apr 11, 2023·1 cites·16 claims
- 1179US2025115591A1Novel sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2024·Application pending·0 cites
- 1276US11926600B2Sulfonylureas and sulfonylthioureas as NLRP3 inhibitorsINFLAZOME LTD·Filed 2018·Granted Mar 12, 2024·1 cites·12 claims
- 1372US11939321B2Benzolactam compounds as protein kinase inhibitorsOTSUKA PHARMA CO LTD·Filed 2021·Granted Mar 26, 2024·0 cites·28 claims
- 1462US2024279237A1Fused bicyclic heteroaryl compounds useful as nlrp3 inhibitorsHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1560US11377443B2Pharmaceutical compoundsCELLCENTRIC LTD·Filed 2020·Granted Jul 5, 2022·0 cites·8 claims
- 1656US10696666B2Pharmaceutical compoundsCELLCENTRIC LTD·Filed 2017·Granted Jun 30, 2020·0 cites·8 claims
- 1755US2021163412A1Novel sulfoneurea compoundsINFLAZOME LTD·Filed 2019·Application pending·0 cites
- 1852US12187702B2Sulfonamideurea compoundsINFLAZOME LTD·Filed 2019·Granted Jan 7, 2025·0 cites·8 claims
- 1952US2022389031A1Macrocyclic sulfonylamide derivatives useful as nlrp3 inhibitorsINFLAZOME LTD·Filed 2020·Application pending·0 cites
- 2051US12221434B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Feb 11, 2025·0 cites·19 claims
- 2150US12168653B2Sulfonamide derivates as NLRP3 inhibitorsINFLAZOME LTD·Filed 2019·Granted Dec 17, 2024·0 cites·18 claims
- 2250US2023121952A1CompoundsINFLAZOME LTD·Filed 2021·Application pending·0 cites
- 2348US2022289766A1Macrocyclic sulfonylurea derivatives useful as nlrp3 inhibitorsINFLAZOME LTD·Filed 2020·Application pending·0 cites
- 2447US11905252B2CompoundsINFLAZOME LTD·Filed 2019·Granted Feb 20, 2024·0 cites·22 claims
- 2546US11773058B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Oct 3, 2023·0 cites·20 claims
- 2646US2022289692A1Nlrp3 inhibitorsINFLAZOME LTD·Filed 2020·Application pending·0 cites
- 2745US2022106289A1Nlrp3 inhibitorsINFLAZOME LTD·Filed 2019·Application pending·0 cites
- 2844US12030879B2Sulfonyl acetamides as NLRP3 inhibitorsINFLAZOME LTD·Filed 2019·Granted Jul 9, 2024·0 cites·23 claims
- 2943US12012392B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Jun 18, 2024·0 cites·20 claims
- 3042US10647704B2Pharmaceutical compoundsCELLCENTRIC LTD·Filed 2017·Granted May 12, 2020·0 cites·8 claims
- 3142US2022106288A1Novel sulfoneurea compoundsINFLAZOME LTD·Filed 2019·Application pending·0 cites
- 3242US2021122739A1Novel sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Application pending·0 cites
- 3341US2020361895A1Novel sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Application pending·0 cites
- 3439US2021261512A1Novel compoundsINFLAZOME LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jonathan Shannon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →